18 maj: UK's Cameron: Shares Hollande's View On Growth
19 maj: UPDATE: Spain Revises 2011 Deficit To 8.9% Of GDP, Maintains 2012..
18-05-2012 23:51:00

UPDATE: Chesapeake Energy Cuts Directors' Compensation By 20%

Relateret indhold

--Beleaguered natural-gas giant cuts directors' pay

--Directors' personal use on partially owned company aircraft is also banned

--Pay cut may not soothe investors' ire

(Adds comments from board member, analyst, updated share price, in the fourth, ninth and 10th paragraphs.)

By Ben Lefebvre

Of DOW JONES NEWSWIRES

HOUSTON -(Dow Jones)- Chesapeake Energy Corp. (CHK) Friday said it will cut total compensation for its board by 20%, the latest move by the beleaguered natural-gas giant to quell criticism over its corporate governance.

A series of revelations detailing possible conflicts-of-interest issues involving Chesapeake Chief Executive Aubrey McClendon has a brought fresh wave of criticism against the company and its board. Doubts about Chesapeake's governance, complicated finances and natural-gas prices near historic lows have cost Chesapeake billions of dollars in market value.

Annual pay for the nine board members will be cut immediately to $100,000 cash and $250,000 in company shares, the company said. Until now, the majority of board members had received total compensation of more than $500,000 a year, with Louis Simpson receiving nearly $600,000 a year in cash and stock awards, according to Chesapeake financial filings.

"We believe these latest changes to the directors' compensation will address concerns raised by shareholders and better align Chesapeake with its peers," said Merrill Miller, Chesapeake's lead independent director and chief executive of National Oilwell Varco Inc. (NOV).

The board also eliminated as a perk board member's personal use of aircraft partially owned by the company.

The changes did little to soothe analysts who have criticized the board as not practicing strong enough oversight of the company, the second-largest natural-gas producer in the U.S. In the latest example of shareholder anger, the custodian of a group of New York pension funds on Thursday called for a vote against the re-election of two board members, saying they failed to properly monitor McClendon in his use of personal stakes in company wells as collateral for loans from companies doing business with Chesapeake.

Meanwhile, S.A.C. Capital Advisors LP, Millennium Management LLC and other large hedge funds and investment-advisory firms have cashed out the majority of their stakes in Chesapeake since the first quarter.

The company's shrinking cash flow and reliance on borrowing have also spooked investors. Its stock has fallen 35.6% this year, settling at $14.36 on Friday.

"The company's problems run deeper than director compensation," Morningstar analyst Mark Hanson said.

Meanwhile, Chesapeake's search for an outside board chairman "is progressing," the company said. Last month, the board said it was stripping McClendon of his position as board chairman after a series of revelations detailing his taking loans from companies doing business with the natural-gas producer.

-By Ben Lefebvre, Dow Jones Newswires; 713-547-9201; ben.lefebvre@dowjones.com; Twitter: @bjlefebvre

(END) Dow Jones Newswires

May 18, 2012 17:51 ET (21:51 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Aktier/tendens: Rolig og let positiv start i vente

28-07-2014 08:15:59
Der er en rolig start på uge 31 i kikkerten, når det danske aktiemarked starter mandagshandlen klokken 9.00.Fredag formåede nogle af de tungeste aktier herhjemm..

Danske Bank: Nye kursmål og anbefalinger efter regnskab - NY2

25-07-2014 15:31:22
En lang række analysehuse har opjusteret kursmålet på Danske Bank efter regnskabet for andet kvartal torsdag.De fleste lægger mellem 5 og 10 kr. til kursmålet f..

Novo Nordisk/analytikere: Europæisk anbefaling vigtigt kryds

25-07-2014 14:07:38
En lægemiddelkomite under den europæiske sundhedsmyndighed, EMA, har anbefalet Novo Nordisks kombinationsprodukt Ideglira. Mens det er positivt, og et vigtigt k..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier: Korrektion på 5-10 pct. sandsynlig - ugebrev
2
Aktier/tendens: Rolig og let positiv start i vente
3
Goldman sænker kortsigtet vurdering af globale aktier
4
Vind: Suzlon falder til laveste niveau i to måneder
5
Obligationer/tendens: Stilhed før stormen

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
28. juli 2014 10:18:16
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140723.1 - EUROWEB3 - 2014-07-28 10:18:16 - 2014-07-28 10:18:16 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x